# Welsh, Carson, Anderson & Stowe

> Welsh, Carson, Anderson & Stowe is a New York private equity firm that concentrates on healthcare and technology, raises institutional funds, buys or backs growing companies, and works with management teams on operations, talent, product, and acquisitions. Founded in 1979, WCAS reports more than $33 billion of committed capital and a history spanning more than 200 portfolio companies. Its narrow sector map and large operating bench distinguish it from broad buyout shops, while its healthcare roll-up record has also brought regulatory scrutiny.

- **Founded:** 1979
- **Headquarters:** New York, United States
- **Founders:** Patrick J. Welsh (Co-founder), Russell L. Carson (Co-founder), Bruce K. Anderson (Co-founder)
- **Team size:** Approximately 100 people in the firm's December 2024 responsible-investment report; LinkedIn lists 51-200 employees.
- **Products:** Healthcare private equity, Technology private equity, Portfolio operations, Institutional fund management
- **Notable:** Raised more than $33 billion of committed capital since 1979., Built a history of more than 200 portfolio companies across healthcare and technology., WCAS XIV closed above $5 billion in 2023, the firm's largest fund at the time, with a reported limited-partner re-up rate of about 95%.

## Products & services

- **Healthcare private equity** — Control and growth investments across care delivery, healthcare IT, payor services and risk-based care, medical technology and the pharmaceutical value chain.
- **Technology private equity** — Investments in B2B software, fintech, payments, data and information services, education, government, GRC, human capital, real estate and supply-chain technology.
- **Portfolio operations** — Operating-partner support spanning talent, go-to-market, data and analytics, cybersecurity, procurement, product, pricing and strategic M&A.
- **Institutional fund management** — Raises and manages private equity partnerships for institutional limited partners and the firm's general partners.

## Achievements

- Raised more than $33 billion of committed capital since 1979.
- Built a history of more than 200 portfolio companies across healthcare and technology.
- WCAS XIV closed above $5 billion in 2023, the firm's largest fund at the time, with a reported limited-partner re-up rate of about 95%.
- Clearwater Analytics went public in 2021 at a $5.9 billion valuation at the close of its first trading day.
- Built and exited investments including Alliance Data, Amdocs, Paycom, Fiserv, US Oncology and USPI.
- Reported more than $11 billion of equity deployed across 100 healthcare platform investments.
- Sold supply-chain risk software company Avetta to EQT in 2024.
- Portfolio company Absorb Software ranked No. 89 in G2's 2026 Top 100 Global Software Companies list.

## Latest updates

- **2026-02** — WCAS said portfolio company Absorb Software was ranked No. 89 in G2's 2026 Top 100 Global Software Companies list.
- **2026-01** — WCAS published the pricing announcement for portfolio company Lumexa Imaging's IPO; the company priced 25 million shares at $18.50, following the December 2025 offering process.
- **2025-09** — Former Mastercard chief Gene Lockhart joined WCAS as an operating partner focused on fintech, data and enterprise software.
- **2025-07** — WCAS made a majority investment in AIA Contract Documents alongside AIA and True Wind Capital.
- **2025-06** — Constitution Surgery Alliance received a strategic investment from WCAS.
- **2025-05** — The FTC approved a final consent order limiting WCAS's involvement with U.S. Anesthesia Partners and requiring notice or approval for certain future hospital-based physician practice investments.

## Links

- Website: https://wcas.com
- LinkedIn: https://www.linkedin.com/company/welsh-carson-anderson-%26-stowe

---

Profile page: https://yespress.io/welsh-carson-anderson-stowe
Published by YesPress — https://yespress.io
Last updated: 2026-08-17